Eventide Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-45,500	Closed	-$13.2M	–	151
2020 Q2	$13.2M	Hold	45,500	–	–	0.3%	87
2020 Q1	$10.8M	Buy	+45,500	New	+$10.4M	0.36%	81
2019 Q2	–	Sell	-26,000	Closed	-$4.78M	–	128
2019 Q1	$4.78M	Sell	26,000 -197,000	-88%	-$36.4M	0.16%	92
2018 Q4	$37M	Sell	223,000 -90,000	-29%	-$15.6M	1.64%	18
2018 Q3	$60.3M	Buy	313,000 +70,000	+29%	+$12.5M	2.22%	7
2018 Q2	$41.3M	Hold	243,000	–	–	1.71%	15
2018 Q1	$39.6M	Buy	243,000 +63,000	+35%	+$10.3M	1.85%	14
2017 Q4	$27M	Hold	180,000	–	–	1.42%	30
2017 Q3	$27.4M	Buy	180,000 +145,400	+420%	+$21.9M	1.55%	25
2017 Q2	$4.46M	Hold	34,600	–	–	0.28%	73
2017 Q1	$3.78M	Hold	34,600	–	–	0.25%	81
2016 Q4	$2.55M	Hold	34,600	–	–	0.17%	91
2016 Q3	$3.02M	Hold	34,600	–	–	0.18%	85
2016 Q2	$2.98M	Hold	34,600	–	–	0.18%	85
2016 Q1	$2.75M	Hold	34,600	–	–	0.15%	94
2015 Q4	$4.35M	Buy	+34,600	New	+$4.18M	0.22%	92